FAAM EUROBAT 2024
BackFT1 - Allergen immunotherapy and Anaphylaxis
Friday 22 Nov, 08:30 AM -
10:00 AM Athens, Greece
Ballroom I
Flash Talk
Abstract Text
08:30
FT-02
Clinical characteristics of food anaphylaxis in patients with hereditary alpha-tryptasemia
Abstract Text
08:37
FT-03
Basophil activation test as a marker of desensitization in Very Low-Dose Multi-Nut Immunotherapy and Very Low-Dose Peanut Oral Immunotherapy
Abstract Text
08:44
FT-04
Management of positive challenges in Allergy Day Hospital through the eyes of Food Allergy Severity Score (FASS score)
Abstract Text
08:51
FT-05
Is milk oral immunotherapy using a home up-dosing protocol a viable and safe treatment for the older milk allergic child?
Abstract Text
09:05
FT-07
Evaluation of the IgEs amount and basophil activity changes during walnut oral immunotherapy
Abstract Text
09:12
FT-08
Prescription and use of epinephrine autoinjectors in pediatric anaphylaxis
Abstract Text
09:26
FT-10
Characterising the severity of probable IgE-mediated food allergy in UK adults
Abstract Text
09:33
FT-11
Tryptase and Complement as Biomarkers of Severe Anaphylaxis: A Study of 126 Patients at a Hospital Clinic (Barcelona, Spain)
Abstract Text
09:40
FT-12
The NAples Pediatric Food Allergy score: a multivariable model for the prediction of food allergy in children
